(Q36263605)

13 August 2017

1 reference

title

Induction of endogenous pathways by antiepileptics and clinical implications (English)

1 reference

13 August 2017

Strolin Benedetti M

1

1 reference

13 August 2017

Ruty B

series ordinal

2

1 reference

13 August 2017

Baltes E

series ordinal

3

1 reference

13 August 2017

language of work or name

1 reference

1 October 2005

1 reference

Fundamental and Clinical Pharmacology

13 August 2017

published in

1 reference

13 August 2017

volume

19

1 reference

13 August 2017

issue

5

1 reference

13 August 2017

page(s)

511-529

1 reference

Relevance of induction of human drug-metabolizing enzymes: pharmacological and toxicological implications

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

Clinical implications of hepatic microsomal enzyme induction by antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

Pathophysiology of bone loss in patients receiving anticonvulsant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

Epilepsy and bone health in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

Phenytoin pharmacokinetics: before and after folic acid administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

Diet modulates the toxicity of cancer chemotherapy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

Elevated plasma concentrations of homocysteine in antiepileptic drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

Changes in phylloquinone epoxidase activity related to prothrombin synthesis and microsomal clotting activity in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

Preparative isolation and characterization of the urinary aglycones of vitamin K1 (phylloquinone) in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

Enzyme induction by phenobarbitone and vitamin K1 disposition in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

Reproductive dysfunction in women with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

Effect of epilepsy and antiepileptic drugs on male reproductive health

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

A mechanistic approach to antiepileptic drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

Antiepileptic-antipsychotic drug interactions: a critical review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

Clinically significant pharmacokinetic drug interactions between antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

Thyroid function in girls with epilepsy with carbamazepine, oxcarbazepine, or valproate monotherapy and after withdrawal of medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

An assessment of udp-glucuronosyltransferase induction using primary human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

A toxicologist's guide to biomarkers of hepatic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

Serum transaminase elevations as indicators of hepatic injury following the administration of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

Alanine aminotransferase in clinical practice. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

Progress in the enzyme diagnosis of liver disease: Reality or illusion?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

Hepatic enzyme induction and leucocyte delta-aminolaevulinic acid synthase activity: studies with carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

Effect of Phenobarbitone on Plasma Apolipoprotein B and Plasma High-Density-Lipoprotein Cholesterol in Normal Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

Serum low-density lipoprotein and high-density lipoprotein cholesterol, and liver size in subjects on drugs inducing hepatic microsomal enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

The effect of chronic phenytoin treatment on serum lipid profile in adult epileptic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

Changes of serum lipid patterns during long-term anticonvulsive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

Expression and inducibility of the human bilirubin UDP-glucuronosyltransferase UGT1A1 in liver and cultured primary hepatocytes: evidence for both genetic and environmental influences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

Oxazepam pharmacokinetics in patients with epilepsy treated long-term with phenytoin alone or in combination with phenobarbitone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

The binding of selected therapeutic drugs to human serum alpha-1 acid glycoprotein and to human serum albumin in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

The effect of liver microsomal enzyme inducing and inhibiting drugs on insulin mediated glucose metabolism in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

Effect of phenobarbitone on hepatic drug-metabolizing enzymes and urinary D-glucaric acid excretion in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

Hepatic enzyme induction and its relationship to urinary D-glucaric acid excretion in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

The increase in urinary excretion of 6 beta-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

Inducing properties of rifabutin, and effects on the pharmacokinetics and metabolism of concomitant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

Dose-dependent induction of cytochrome P450 (CYP) 3A4 and activation of pregnane X receptor by topiramate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

CYP3A4 induction by drugs: correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

Some common issues in the use of antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

Safety profile of levetiracetam

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

Enzyme induction by drugs. Its relevance to clinical biochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2005.00341.X

10.1111/J.1472-8206.2005.00341.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference